A citation-based method for searching scientific literature


List of co-cited articles
313 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Standardisation of spirometry.
M R Miller, J Hankinson, V Brusasco, F Burgos, R Casaburi, A Coates, R Crapo, P Enright, C P M van der Grinten, P Gustafsson,[...]. Eur Respir J 2005
11

Development and first validation of the COPD Assessment Test.
P W Jones, G Harding, P Berry, I Wiklund, W-H Chen, N Kline Leidy. Eur Respir J 2009
8

Small-airway obstruction and emphysema in chronic obstructive pulmonary disease.
John E McDonough, Ren Yuan, Masaru Suzuki, Nazgol Seyednejad, W Mark Elliott, Pablo G Sanchez, Alexander C Wright, Warren B Gefter, Leslie Litzky, Harvey O Coxson,[...]. N Engl J Med 2011
644
8

COPD exacerbations: defining their cause and prevention.
Jadwiga A Wedzicha, Terence A R Seemungal. Lancet 2007
577
8

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.
Claus F Vogelmeier, Gerard J Criner, Fernando J Martinez, Antonio Anzueto, Peter J Barnes, Jean Bourbeau, Bartolome R Celli, Rongchang Chen, Marc Decramer, Leonardo M Fabbri,[...]. Am J Respir Crit Care Med 2017
8

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Klaus F Rabe, Suzanne Hurd, Antonio Anzueto, Peter J Barnes, Sonia A Buist, Peter Calverley, Yoshinosuke Fukuchi, Christine Jenkins, Roberto Rodriguez-Roisin, Chris van Weel,[...]. Am J Respir Crit Care Med 2007
8

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Jørgen Vestbo, Suzanne S Hurd, Alvar G Agustí, Paul W Jones, Claus Vogelmeier, Antonio Anzueto, Peter J Barnes, Leonardo M Fabbri, Fernando J Martinez, Masaharu Nishimura,[...]. Am J Respir Crit Care Med 2013
7

Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
Chen Wang, Jianying Xu, Lan Yang, Yongjian Xu, Xiangyan Zhang, Chunxue Bai, Jian Kang, Pixin Ran, Huahao Shen, Fuqiang Wen,[...]. Lancet 2018
376
7

Interpretative strategies for lung function tests.
R Pellegrino, G Viegi, V Brusasco, R O Crapo, F Burgos, R Casaburi, A Coates, C P M van der Grinten, P Gustafsson, J Hankinson,[...]. Eur Respir J 2005
6

Susceptibility to exacerbation in chronic obstructive pulmonary disease.
John R Hurst, Jørgen Vestbo, Antonio Anzueto, Nicholas Locantore, Hana Müllerova, Ruth Tal-Singer, Bruce Miller, David A Lomas, Alvar Agusti, William Macnee,[...]. N Engl J Med 2010
6

Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.
Prescott G Woodruff, R Graham Barr, Eugene Bleecker, Stephanie A Christenson, David Couper, Jeffrey L Curtis, Natalia A Gouskova, Nadia N Hansel, Eric A Hoffman, Richard E Kanner,[...]. N Engl J Med 2016
320
6

Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
Jadwiga A Wedzicha, Donald Banerji, Kenneth R Chapman, Jørgen Vestbo, Nicolas Roche, R Timothy Ayers, Chau Thach, Robert Fogel, Francesco Patalano, Claus F Vogelmeier. N Engl J Med 2016
476
6

Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease.
Surya P Bhatt, Xavier Soler, Xin Wang, Susan Murray, Antonio R Anzueto, Terri H Beaty, Aladin M Boriek, Richard Casaburi, Gerard J Criner, Alejandro A Diaz,[...]. Am J Respir Crit Care Med 2016
182
6

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
J J Soler-Cataluña, M A Martínez-García, P Román Sánchez, E Salcedo, M Navarro, R Ochando. Thorax 2005
6

Clinical and Radiologic Disease in Smokers With Normal Spirometry.
Elizabeth A Regan, David A Lynch, Douglas Curran-Everett, Jeffrey L Curtis, John H M Austin, Philippe A Grenier, Hans-Ulrich Kauczor, William C Bailey, Dawn L DeMeo, Richard H Casaburi,[...]. JAMA Intern Med 2015
217
6

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Donald P Tashkin, Bartolome Celli, Stephen Senn, Deborah Burkhart, Steven Kesten, Shailendra Menjoge, Marc Decramer. N Engl J Med 2008
6


Site and nature of airway obstruction in chronic obstructive lung disease.
J C Hogg, P T Macklem, W M Thurlbeck. N Engl J Med 1968
5

Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
Henrik Watz, Kay Tetzlaff, Emiel F M Wouters, Anne Kirsten, Helgo Magnussen, Roberto Rodriguez-Roisin, Claus Vogelmeier, Leonardo M Fabbri, Pascal Chanez, Ronald Dahl,[...]. Lancet Respir Med 2016
247
5

The nature of small-airway obstruction in chronic obstructive pulmonary disease.
James C Hogg, Fanny Chu, Soraya Utokaparch, Ryan Woods, W Mark Elliott, Liliana Buzatu, Ruben M Cherniack, Robert M Rogers, Frank C Sciurba, Harvey O Coxson,[...]. N Engl J Med 2004
5

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.
David A Lipson, Frank Barnhart, Noushin Brealey, Jean Brooks, Gerard J Criner, Nicola C Day, Mark T Dransfield, David M G Halpin, MeiLan K Han, C Elaine Jones,[...]. N Engl J Med 2018
420
5

Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials.
Mona Bafadhel, Stefan Peterson, Miguel A De Blas, Peter M Calverley, Stephen I Rennard, Kai Richter, Malin Fagerås. Lancet Respir Med 2018
164
5

Spirometric reference values from a sample of the general U.S. population.
J L Hankinson, J R Odencrantz, K B Fedan. Am J Respir Crit Care Med 1999
5

Impact and prevention of severe exacerbations of COPD: a review of the evidence.
David Mg Halpin, Marc Miravitlles, Norbert Metzdorf, Bartolomé Celli. Int J Chron Obstruct Pulmon Dis 2017
68
7

Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.
Peter Lange, Bartolome Celli, Alvar Agustí, Gorm Boje Jensen, Miguel Divo, Rosa Faner, Stefano Guerra, Jacob Louis Marott, Fernando D Martinez, Pablo Martinez-Camblor,[...]. N Engl J Med 2015
532
5

Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations.
Philip H Quanjer, Sanja Stanojevic, Tim J Cole, Xaver Baur, Graham L Hall, Bruce H Culver, Paul L Enright, John L Hankinson, Mary S M Ip, Jinping Zheng,[...]. Eur Respir J 2012
5

Tiotropium + olodaterol shows clinically meaningful improvements in quality of life.
Dave Singh, Gary T Ferguson, Josef Bolitschek, Lars Grönke, Christoph Hallmann, Nathan Bennett, Roger Abrahams, Olaf Schmidt, Leif Bjermer. Respir Med 2015
103
5



An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease.
Mark D Eisner, Nicholas Anthonisen, David Coultas, Nino Kuenzli, Rogelio Perez-Padilla, Dirkje Postma, Isabelle Romieu, Edwin K Silverman, John R Balmes. Am J Respir Crit Care Med 2010
516
4

Characterisation of COPD heterogeneity in the ECLIPSE cohort.
Alvar Agusti, Peter M A Calverley, Bartolome Celli, Harvey O Coxson, Lisa D Edwards, David A Lomas, William MacNee, Bruce E Miller, Steve Rennard, Edwin K Silverman,[...]. Respir Res 2010
720
4

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
Bartolome R Celli, Claudia G Cote, Jose M Marin, Ciro Casanova, Maria Montes de Oca, Reina A Mendez, Victor Pinto Plata, Howard J Cabral. N Engl J Med 2004
4

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
Rafael Lozano, Mohsen Naghavi, Kyle Foreman, Stephen Lim, Kenji Shibuya, Victor Aboyans, Jerry Abraham, Timothy Adair, Rakesh Aggarwal, Stephanie Y Ahn,[...]. Lancet 2012
4

Inhaled corticosteroids in COPD: friend or foe?
Alvar Agusti, Leonardo M Fabbri, Dave Singh, Jørgen Vestbo, Bartolome Celli, Frits M E Franssen, Klaus F Rabe, Alberto Papi. Eur Respir J 2018
84
4

Chronic obstructive pulmonary disease phenotypes: the future of COPD.
MeiLan K Han, Alvar Agusti, Peter M Calverley, Bartolome R Celli, Gerard Criner, Jeffrey L Curtis, Leonardo M Fabbri, Jonathan G Goldin, Paul W Jones, William Macnee,[...]. Am J Respir Crit Care Med 2010
636
4

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
Peter M A Calverley, Julie A Anderson, Bartolome Celli, Gary T Ferguson, Christine Jenkins, Paul W Jones, Julie C Yates, Jørgen Vestbo. N Engl J Med 2007
4

Treatable traits: toward precision medicine of chronic airway diseases.
Alvar Agusti, Elisabeth Bel, Mike Thomas, Claus Vogelmeier, Guy Brusselle, Stephen Holgate, Marc Humbert, Paul Jones, Peter G Gibson, Jørgen Vestbo,[...]. Eur Respir J 2016
439
4

C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations.
Christopher C Butler, David Gillespie, Patrick White, Janine Bates, Rachel Lowe, Emma Thomas-Jones, Mandy Wootton, Kerenza Hood, Rhiannon Phillips, Hasse Melbye,[...]. N Engl J Med 2019
72
5

Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression.
Craig J Galbán, Meilan K Han, Jennifer L Boes, Komal A Chughtai, Charles R Meyer, Timothy D Johnson, Stefanie Galbán, Alnawaz Rehemtulla, Ella A Kazerooni, Fernando J Martinez,[...]. Nat Med 2012
389
4

Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality.
Surya P Bhatt, Pallavi P Balte, Joseph E Schwartz, Patricia A Cassano, David Couper, David R Jacobs, Ravi Kalhan, George T O'Connor, Sachin Yende, Jason L Sanders,[...]. JAMA 2019
44
9

Noninvasive Imaging Biomarker Identifies Small Airway Damage in Severe Chronic Obstructive Pulmonary Disease.
Dragoş M Vasilescu, Fernando J Martinez, Nathaniel Marchetti, Craig J Galbán, Charles Hatt, Catherine A Meldrum, Chandra Dass, Naoya Tanabe, Rishindra M Reddy, Amir Lagstein,[...]. Am J Respir Crit Care Med 2019
47
8

At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.
Fernando J Martinez, MeiLan K Han, James P Allinson, R Graham Barr, Richard C Boucher, Peter M A Calverley, Bartolome R Celli, Stephanie A Christenson, Ronald G Crystal, Malin Fagerås,[...]. Am J Respir Crit Care Med 2018
88
4

Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.
Davies Adeloye, Stephen Chua, Chinwei Lee, Catriona Basquill, Angeliki Papana, Evropi Theodoratou, Harish Nair, Danijela Gasevic, Devi Sridhar, Harry Campbell,[...]. J Glob Health 2015
354
4



LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis.
Gustavo J Rodrigo, David Price, Antonio Anzueto, Dave Singh, Pablo Altman, Giovanni Bader, Francesco Patalano, Robert Fogel, Konstantinos Kostikas. Int J Chron Obstruct Pulmon Dis 2017
71
5

Genetic epidemiology of COPD (COPDGene) study design.
Elizabeth A Regan, John E Hokanson, James R Murphy, Barry Make, David A Lynch, Terri H Beaty, Douglas Curran-Everett, Edwin K Silverman, James D Crapo. COPD 2010
673
4

Global burden of COPD: systematic review and meta-analysis.
R J Halbert, J L Natoli, A Gano, E Badamgarav, A S Buist, D M Mannino. Eur Respir J 2006
853
4

An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.
Martijn A Spruit, Sally J Singh, Chris Garvey, Richard ZuWallack, Linda Nici, Carolyn Rochester, Kylie Hill, Anne E Holland, Suzanne C Lareau, William D-C Man,[...]. Am J Respir Crit Care Med 2013
4



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.